Hot Keywords
Biomarker Discovery Autophagy and Cancer Breast Cancer Metastasis Brain Metastases Gastric Cancer Metastasis Lung Cancer Genetic Heterogeneity Colorectal Cancer Prostate Cancer Cancer Immunotherapy Circulating Tumor Cells Neuroendocrine Tumors

Top

Chair(s)

  • Dr. Pravin D. Potdar

    Former Head & Chief, Department of Molecular Medicine & Biology, Jaslok Hospital & Research Centre, Mumbai, India.
    Chairman, Institutional Ethics Committee (IEC), Dr. A.P.J. Abdul Kalam Educational & Research Centre, Indian Dental Association (IDA), Mumbai, India.

Speaker(s)

  • Dr. Debasmita Dutt

    Research Fellow, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

  • Dr. Rekha Pal

    Director, Scientific Engagement, Crown Biosciences, USA.

  • Dr. Lopamudra Das Roy

    Founder & President, Breast Cancer Hub, Social Entrepreneur, Keynote Speaker, Distinguished Cancer Scientist, Concord, North Carolina, USA.

  • Dr. Geetha Manjunath

    Founder & CEO of Niramai Health Analytix, Bengaluru, Karnataka, India.

  • Dr. Harsh Sheth

    Assistant professor and Head of Advanced Genomic Technologies Division at FRIGE's Institute of Human Genetics, Ahmedabad, Gujarat, India.

  • Dr. Manash Paul

    Scientist, Principal Investigator, Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, USA.

  • Dr. Amrit Kaur Kaler

    Consultant, Molecular Pathology, Kokilaben Dhirubhai Ambani Hospital & Research Centre, Mumbai, Maharashtra, India.

  • Dr. Aloukick Kumar Singh

    Former Research Scientist, M.D. Anderson Cancer Centre, Houston, Texas, USA
    Presently Scientist, Centre of Stem Cell Research, CMC, Vellore, Tamil Nadu, India.

  • Dr. Rohidas Arote

    Associate Professor, Seoul National University, Seoul, South Korea.

Programme

      Time (India)
      Speakers
      Topics
      17:30-17:40
      Pravin D. Potdar
      Welcome Speech and Brief Introduction of JCMT
      17:40-18:00
      Debasmita Dutt
      Nanoengineered drug delivery systems to target tumor microenvironment: A promising and safe alternative of chemotherapy
      18:00-18:10
      /
      Discussion
      18:10-18:30
      Rekha Pal
      Exploring immunotherapies within a novel immune-oncology organoid model
      18:30-18:40
      /
      Discussion
      18:40-19:00
      Lopamudra Das Roy
      Connecting Research to Community, Saving Lives
      19:00-19:10
      /
      Discussion
      19:10-19:30
      Harsh Sheth
      Diagnostics & Preventive program in hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome in India- A Low Hanging Fruit of Detection
      19:30-19:40
      /
      Discussion
      19:40-20:00
      Geetha Manjunath
      Latest early detection program in Breast Cancer
      20:00-20:10
      /
      Discussion
      20:10-20:30
      Manash Paul
      Lung Cancer Organoids & Drug Discovery
      20:30-20:40
      /
      Discussion
      20:40-21:00
      Amrit Kaur Kaler
      Role of Targeted Therapy in Cancer Therapeutics
      21:00-21:10
      /
      Discussion
      21:10-21:30
      Aloukick Kumar Singh
      Towards off-the-shelf CAR-T cells
      21:30-21:40
      /
      Discussion
      21:40-22:00
      Rohidas Arote
      Development of Multifunctional Nanocarriers for Gene Therapy Applications
      22:00-22:10
      /
      Discussion
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties